Despite the potential of digital health therapies to revolutionize healthcare, adoption and development remain complex challenges. How do we define and characterise digital health therapies? What is the current state of the regulatory and reimbursement pathways for digital health and how does it impact the development of the sector? What initiatives are underway to promote interoperability and data sharing? What are the key components of successful value proposition and revenue model for digital health innovations? How do investment strategies of VCs and big players influence the development and adoption of the innovative technologies in the sector? How can further collaboration between healthcare providers, regulators, industry, and patients accelerate their adoption?
Moderator: Susie A. Ruff, Founder & Strategic Advisor, RUFF & CO. Business Innovation 
